IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 125 filers reported holding IMMUNOVANT INC in Q1 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,151,068 | +81.2% | 56,032 | -10.5% | 0.00% | +100.0% |
| Q2 2023 | $1,187,408 | +51.9% | 62,594 | +24.2% | 0.00% | 0.0% |
| Q1 2023 | $781,734 | -10.0% | 50,402 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $868,171 | +285.9% | 48,911 | +21.4% | 0.00% | – |
| Q3 2022 | $225,000 | +55.2% | 40,279 | +8.8% | 0.00% | – |
| Q2 2022 | $145,000 | -24.5% | 37,013 | +6.1% | 0.00% | – |
| Q1 2022 | $192,000 | -4.0% | 34,873 | +48.6% | 0.00% | – |
| Q4 2021 | $200,000 | +7.5% | 23,460 | +9.4% | 0.00% | – |
| Q3 2021 | $186,000 | -74.3% | 21,440 | -68.7% | 0.00% | – |
| Q2 2021 | $724,000 | -6.6% | 68,579 | +42.0% | 0.00% | – |
| Q1 2021 | $775,000 | -74.4% | 48,312 | -26.4% | 0.00% | -100.0% |
| Q4 2020 | $3,029,000 | +120.1% | 65,604 | +67.8% | 0.00% | 0.0% |
| Q3 2020 | $1,376,000 | +323.4% | 39,086 | +192.2% | 0.00% | – |
| Q2 2020 | $325,000 | – | 13,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 1,439,544 | $22,327,327 | 8.67% |
| Logos Global Management LP | 2,500,000 | $38,775,000 | 5.55% |
| Deep Track Capital, LP | 7,432,717 | $115,281,441 | 4.74% |
| COMMODORE CAPITAL LP | 1,440,999 | $22,349,894 | 3.40% |
| Ikarian Capital, LLC | 774,398 | $12,010,913 | 2.72% |
| COWEN AND COMPANY, LLC | 1,250,000 | $19,387,500 | 2.28% |
| HighVista Strategies LLC | 163,799 | $2,540,522 | 2.07% |
| TCG Crossover Management, LLC | 654,853 | $10,156,770 | 1.98% |
| BVF INC/IL | 2,561,000 | $39,721,110 | 1.45% |
| Redmile Group, LLC | 1,317,031 | $20,427,151 | 0.89% |